MEHCQ — 23andMe Holding Co Income Statement
0.000.00%
Last trade - 00:00- $24.14m
- -$55.21m
- $219.64m
Annual income statement for 23andMe Holding Co, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 305 | 244 | 272 | 299 | 220 |
| Cost of Revenue | |||||
| Gross Profit | 137 | 117 | 133 | 134 | 99.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 564 | 429 | 526 | 624 | 901 |
| Operating Profit | -258 | -185 | -254 | -324 | -681 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -251 | -184 | -221 | -314 | -667 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -251 | -184 | -217 | -312 | -667 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -251 | -184 | -217 | -312 | -667 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -251 | -184 | -217 | -312 | -667 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -107 | -84.3 | -12 | -13.5 | -18.2 |